Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |